The Complete Clinical Study Report of Phase-III Trials of DRDO's 2DG Oral Drug in Moderate ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'The complete clinical study report of Phase-III trials of DRDO's 2DG oral drug in moderate to severe COVID-19 patients is expected to be available by the end of August 2021: Ministry of Chemicals & Fertilizers in Lok Sabha'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)